نتایج جستجو برای: ad 40

تعداد نتایج: 415783  

Journal: :Alzheimers & Dementia 2023

Background Cerebrospinal fluid (CSF) Alzheimer’s disease (AD) biomarkers are used to clinically diagnose AD with an accuracy of 70-80%. However, they invasive and expensive need be further studied on preclinical-AD. Additionally, a blood-based biomarker can great use. In order obtain biomarker, we have sequenced plasma cell-free RNA (cfRNA) from preclinical-AD individuals develop prediction mod...

Journal: :International Journal of Molecular Sciences 2023

Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder, hallmarked by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles. Due to uncertainty pathogenesis AD, strategies aimed at suppressing neuroinflammation fostering synaptic repair are eagerly sought. Asiaticoside (AS), natural triterpenoid derivative derived from Centella asiatica, known for its anti-inflammat...

Journal: :The Journal of allergy and clinical immunology 2010
Lena F Schimke Julie Sawalle-Belohradsky Joachim Roesler Andreas Wollenberg Anita Rack Michael Borte Nikolaus Rieber Reinhold Cremer Eberhart Maass Roland Dopfer Janine Reichenbach Volker Wahn Manfred Hoenig Annette F Jansson Angela Roesen-Wolff Bianca Schaub Reinhard Seger Harry R Hill Hans D Ochs Troy R Torgerson Bernd H Belohradsky Ellen D Renner

BACKGROUND Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema. The association of heterozygous signal transducer and activator of transcription 3 (STAT3) mutations with autosomal dominant (AD)-HIES allows the differentiation of AD-HIES from disorders associated with eczem...

2016
Jerry M. Cuttler Eugene R. Moore Victor D. Hosfeld David L. Nadolski

Alzheimer disease (AD) primarily affects older adults. This neurodegenerative disorder is the most common cause of dementia and is a leading source of their morbidity and mortality. Patient care costs in the United States are about 200 billion dollars and will more than double by 2040. This case report describes the remarkable improvement in a patient with advanced AD in hospice who received 5 ...

2016
Samuel N Lockhart Suzanne L Baker Nobuyuki Okamura Katsutoshi Furukawa Aiko Ishiki Shozo Furumoto Manabu Tashiro Kazuhiko Yanai Hiroyuki Arai Yukitsuka Kudo Ryuichi Harada Naoki Tomita Kotaro Hiraoka Shoichi Watanuki William J Jagust

BACKGROUND [18F]THK5351, a recently-developed positron emission tomography (PET) tracer for measuring tau neurofibrillary tangle accumulation, may help researchers examine aging, disease, and tau pathology in living human brains. We examined THK5351 tracer pharmacokinetics to define an optimal acquisition time for static late images. METHODS Primary measurements were calculation of regional v...

Journal: :Age and ageing 1996
S T O'Keeffe H Kazeem R M Philpott J R Playfer M Gosney M Lye

Gait disturbance is common in patients with Alzheimer's disease (AD). The aim of this study was to analyse the clinical gait syndromes of patients with AD using Nutt's classification. Fifty-five patients who satisfied the NINCDS-ADRDA criteria for probable AD and 55 controls were recruited from a geriatric and a psychogeriatric unit. Patients with classical musculoskeletal or neurological syndr...

2011
Catherine Féart Catherine Helmer Hervé Fleury Yannick Béjot Karen Ritchie Philippe Amouyel Susanna Schraen-Maschke Luc Buée Jean-Charles Lambert Luc Letenneur Jean-François Dartigues

OBJECTIVE Herpes simplex virus (HSV) reactivation has been identified as a possible risk factor for Alzheimer's disease (AD) and plasma amyloid-beta (Aβ) levels might be considered as possible biomarkers of the risk of AD. The aim of our study was to investigate the association between anti-HSV antibodies and plasma Aβ levels. METHODS The study sample consisted of 1222 subjects (73.9 y in mea...

Journal: :Journal of Alzheimer's disease : JAD 2013
Virginia Pérez-Grijalba Pedro Pesini Inmaculada Monleón Mercè Boada Lluís Tárraga Agustín Ruiz-Laza Pablo Martínez-Lage Itziar San-José Manuel Sarasa

Validation of cost-effective, non-invasive methods to identify early (pre-clinical) Alzheimer's disease (AD) is increasingly becoming a key research challenge. We have developed two ELISA sandwich colorimetric tests for the accurate detection of amyloid-β (Aβ)1-40 and Aβ1-42: i) directly accessible (DA) in the plasma, ii) recovered from the plasma sample (RP) after diluting the plasma sample in...

Journal: :Nevrologiâ, nejropsihiatriâ, psihosomatika 2022

Genetic polymorphisms associated with impaired one-carbon metabolism (1-CM) can be a risk factor not only for somatic and neurological diseases, but also affective disorders (AD). Objective : to compare the frequency of genetic MTHFR, MTR, MTRR 1-CM among patients AD, their blood relatives healthy individuals. Patients methods . This cross-sectional study ( ) included AD (n=24), (n=40), as well...

2018
Maria Bjerke Sebastiaan Engelborghs

An accurate and early diagnosis of Alzheimer's disease (AD) is important to select optimal patient care and is critical in current clinical trials targeting core AD neuropathological features. The past decades, much progress has been made in the development and validation of cerebrospinal fluid (CSF) biomarkers for the biochemical diagnosis of AD, including standardization and harmonization of ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید